Chris Holland
Head of Biostatistics, Immunocore
Chris Holland has been a SAS user since 1990 in a variety of settings ranging from academia, contract research organizations, regulatory agencies, and both small and large pharmaceutical and biotechnology companies. He was first introduced to CDISC while working as a statistical reviewer at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration. There he served as the technical lead for the SDTM/ADaM Pilot Project FDA review team and invented an early version of the MAED Service, an adverse event review tool that made use of data standards and is currently in production at the FDA. Since leaving the FDA, Holland continues to be active in the CDISC community, particularly with the ADaM team. He received an MS in statistics from the University of Virginia, a BS in statistics from Virginia Tech, and is an Accredited Professional Statistician™ by the American Statistical Association.
By This Author
Implementing CDISC Using SAS®: An End-to-End Guide, Revised Second Edition
By Chris Holland and Jack Shostak
Comprehensive guide on applying clinical research data and metadata to the CDISC standards. This edition reflects the 2017 FDA mandate for adherence to CDISC standards. Revised to add the latest C-Codes as well as update the make_define macro that accompanies this book in order to add the capability to handle C-Codes.
*Our books are also available in print and e-book formats
from your local bookstore or favorite online bookseller.
Implementing CDISC Using SAS®: An End-to-End Guide, Second Edition
By Chris Holland and Jack Shostak
*Replaced by a revised edition Implementing CDISC Using SAS®: An End-to-End Guide, Revised Second Edition
Implementing CDISC Using SAS®: An End-to-End Guide
By Chris Holland and Jack Shostak
*Replaced by a new edition, Implementing CDISC Using SAS®: An End-to-End Guide, Second Edition
Featured Authors
-
Todd Case has been working in the pharmaceutical industry as a statistical programmer for over 20 years. He completed his MS in Epidemiology from Columbia University and has worked at Forest Laboratories (now Allergan), Genentech, Bristol-Myers Squibb, and Biogen. He currently works at Vertex Pharmaceuticals.
-
Ron Klimberg, PhD, is a professor at the Haub School of Business at Saint Joseph's University in Philadelphia, PA.
-
Robert N. Rodriguez retired from SAS in 2018 after serving as a senior director in research and development. Bob received a PhD in statistics from the University of North Carolina at Chapel Hill and was a research statistician at General Motors Research Laboratories before joining SAS.
-
Terisa Roberts is a director and Global Solution lead for Risk Modeling and Decisioning at SAS. She has extensive experience in quantitative risk management, regulatory compliance, and model governance and validation. She has worked in financial services, telecommunications, government, energy, and retail sectors.